| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700782 | European Journal of Surgical Oncology (EJSO) | 2017 | 9 Pages |
Abstract
This study suggests that NIRF imaging identifies significantly more and smaller tumors during resection of CRLM, preventing recurrences in a subset of patients. Given its safety profile and low expense, routine use can be considered until tumor targeting fluorescent tracers are clinically available.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
H.J.M. Handgraaf, L.S.F. Boogerd, D.J. Höppener, A. Peloso, B.G. Sibinga Mulder, C.E.S. Hoogstins, H.H. Hartgrink, C.J.H. van de Velde, J.S.D. Mieog, R.J. Swijnenburg, H. Putter, M. Maestri, A.E. Braat, J.V. Frangioni, A.L. Vahrmeijer,